Immunomodulation

BIOGRAPHY

Dr. Blazar is a professor of pediatrics in the Division of Hematology-Oncology and Blood and Marrow Transplantation and attends on the Pediatric Blood and Marrow Transplantation (BMT) service. He is the director of the Center for Translational Medicine, created to bring innovative, early phase therapies into the clinic. He also is principal investigator for the Clinical and Translational Sciences Institute that is being established and designed to transform health through clinical translational science, and community and university partnerships by streamlining and facilitating community-relevant research while collaborating across disciplines, organizations, and communities.

Dr. Blazar has served as a past chair of the National Institutes of Health Cancer Immunopathology and Immunotherapy Study Section, Food and Drug Administration Biological Response Modifiers Advisory Committee, and the Leukemia and Lymphoma Translational Research Award Committee. He is a current member of the American Society of Gene Therapy Immunology Committee, Immune Tolerance Network Executive Committee, and the National Cancer Institute Board of Scientific Counselors for Clinical Sciences and Epidemiology, Center for Cancer Research. Dr. Blazar is the recipient of an NIH MERIT Award and is the principal investigator of several other NIH-funded studies focusing on BMT and cancer immunobiology in preclinical model systems and in the clinic. He is the recipient of the Andersen Chair in Transplantation Immunology and a member of the Academic Health Center's Academy of Excellence in Health Research which recognize his pioneering work in the development of novel immune-based therapies. He is the author of more than 400 manuscripts, which have appeared in premier peer-reviewed publications.